CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 39 filers reported holding CYTOSORBENTS CORP in Q4 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $351,000 | +2.0% | 64,489 | +19.9% | 0.00% | – |
| Q3 2016 | $344,000 | +40.4% | 53,807 | -0.2% | 0.00% | – |
| Q2 2016 | $245,000 | +61.2% | 53,915 | +39.3% | 0.00% | – |
| Q1 2016 | $152,000 | -34.5% | 38,712 | -6.9% | 0.00% | – |
| Q4 2015 | $232,000 | -7.6% | 41,596 | +4.5% | 0.00% | – |
| Q3 2015 | $251,000 | 0.0% | 39,795 | -2.6% | 0.00% | – |
| Q2 2015 | $251,000 | – | 40,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |